F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Metabolic dysfunction-associated steatotic liver disease

Page 1 of 3 ( 118 items )
<<
1
2
3
>>

1	Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials 4/3/2026 6:41:52 AM \| Browse: 2 \| Download: 0
2	Exercise-responsive skeletal muscle genes mechanistically linked to metabolic dysfunction-associated steatotic liver disease 3/27/2026 6:07:06 AM \| Browse: 11 \| Download: 39
3	Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease 3/27/2026 6:07:05 AM \| Browse: 17 \| Download: 13
4	Role of hepatic sonic hedgehog protein expression in the diagnosis of metabolic dysfunction-associated steatohepatitis 3/19/2026 7:07:30 AM \| Browse: 15 \| Download: 64
5	Zhejiang University index - connecting type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: Clinical utility and future horizons 3/12/2026 9:18:15 AM \| Browse: 10 \| Download: 54
6	Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes 3/6/2026 8:56:27 AM \| Browse: 35 \| Download: 148
7	Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation 2/27/2026 8:35:11 AM \| Browse: 17 \| Download: 89
8	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 47 \| Download: 218
9	Liver clock: Malalignment and entrainment therapeutics 2/11/2026 3:41:43 AM \| Browse: 33 \| Download: 84
10	Fatty pancreas: Current insights and future perspectives 2/10/2026 10:35:39 AM \| Browse: 33 \| Download: 88
11	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies 2/6/2026 8:43:37 AM \| Browse: 61 \| Download: 126
12	High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health 2/2/2026 7:26:02 AM \| Browse: 38 \| Download: 134
13	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 43 \| Download: 170
14	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 37 \| Download: 140
15	Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study 1/27/2026 10:12:31 AM \| Browse: 35 \| Download: 118
16	Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction 1/27/2026 10:12:31 AM \| Browse: 40 \| Download: 124
17	Metabolic-dysfunction associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review 1/15/2026 8:12:50 AM \| Browse: 36 \| Download: 85
18	Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches 1/12/2026 9:50:50 AM \| Browse: 31 \| Download: 78
19	Serum uric acid-to-high-density lipoprotein cholesterol ratio and cardiovascular risk in Asian patients with metabolic dysfunction-associated steatotic liver disease 12/27/2025 2:50:52 AM \| Browse: 51 \| Download: 195
20	Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption? 12/26/2025 10:27:35 AM \| Browse: 61 \| Download: 182
21	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 70 \| Download: 302
22	Integrated serum metabolomics reveal molecular mechanism of Xietu Hemu prescription on metabolic dysfunction-associated steatotic liver disease-related obesity 12/26/2025 10:27:31 AM \| Browse: 62 \| Download: 247
23	Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health 12/26/2025 10:27:30 AM \| Browse: 75 \| Download: 235
24	Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease 12/22/2025 7:43:01 AM \| Browse: 57 \| Download: 179
25	Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease 12/19/2025 10:39:41 AM \| Browse: 67 \| Download: 274
26	Artificial intelligence applications for managing metabolic dysfunction-associated steatotic liver disease: Current status and future prospects 12/19/2025 10:39:40 AM \| Browse: 58 \| Download: 233
27	Role of sodium-glucose co-transporter 2 inhibitors in liver diseases 12/19/2025 8:32:37 AM \| Browse: 57 \| Download: 198
28	Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients 12/15/2025 9:46:09 AM \| Browse: 40 \| Download: 167
29	Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis 12/10/2025 7:48:07 AM \| Browse: 101 \| Download: 274
30	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 78 \| Download: 190
31	Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges 12/3/2025 9:10:07 AM \| Browse: 108 \| Download: 252
32	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 71 \| Download: 212
33	Impact of alcohol-associated and metabolic dysfunction-associated steatotic liver diseases upon hepatic disorder and carcinogenesis in the current era 11/27/2025 7:53:59 AM \| Browse: 66 \| Download: 204
34	Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology 11/27/2025 7:53:58 AM \| Browse: 57 \| Download: 202
35	Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis 11/27/2025 7:53:58 AM \| Browse: 65 \| Download: 265
36	Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Machine learning for non-invasive diagnosis and risk stratification 11/27/2025 7:53:57 AM \| Browse: 47 \| Download: 153
37	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 51 \| Download: 174
38	Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action 11/27/2025 7:53:52 AM \| Browse: 51 \| Download: 182
39	Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease 11/26/2025 3:57:03 AM \| Browse: 65 \| Download: 244
40	Clinical significance and pathogenic mechanisms of fatigue in metabolic dysfunction-associated steatotic liver disease 10/27/2025 10:57:53 AM \| Browse: 168 \| Download: 291
41	Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications 10/27/2025 10:57:50 AM \| Browse: 183 \| Download: 205
42	Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice 10/27/2025 10:57:49 AM \| Browse: 143 \| Download: 300
43	Helicobacter pylori infection as a risk factor in the development of Metabolic dysfunction-associated steatotic liver disease 10/27/2025 10:57:49 AM \| Browse: 159 \| Download: 235
44	Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease 10/27/2025 8:08:13 AM \| Browse: 165 \| Download: 367
45	Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus 10/15/2025 9:03:22 AM \| Browse: 83 \| Download: 481
46	Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases 9/25/2025 11:24:06 AM \| Browse: 94 \| Download: 120
47	From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease 9/25/2025 11:24:04 AM \| Browse: 139 \| Download: 218
48	Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation 9/25/2025 11:24:01 AM \| Browse: 129 \| Download: 260
49	Silymarin-alpha lipoic acid and metabolic dysfunction-associated steatotic liver disease: Insights and methodological considerations 9/25/2025 11:24:00 AM \| Browse: 100 \| Download: 203
50	Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool 9/25/2025 3:33:09 AM \| Browse: 116 \| Download: 152

Page 1 of 3 ( 118 items )
<<
1
2
3
>>

1	Roles of hepatic immunity in metabolic dysfunction-associated steatotic liver disease: Cellular and molecular mechanisms and clinical trials 4/3/2026 6:41:52 AM \| Browse: 2 \| Download: 0
2	Exercise-responsive skeletal muscle genes mechanistically linked to metabolic dysfunction-associated steatotic liver disease 3/27/2026 6:07:06 AM \| Browse: 11 \| Download: 39
3	Outcomes of liver and cardiovascular metabolic diseases among lean vs non-lean individuals with metabolic dysfunction-associated steatotic liver disease 3/27/2026 6:07:05 AM \| Browse: 17 \| Download: 13
4	Role of hepatic sonic hedgehog protein expression in the diagnosis of metabolic dysfunction-associated steatohepatitis 3/19/2026 7:07:30 AM \| Browse: 15 \| Download: 64
5	Zhejiang University index - connecting type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: Clinical utility and future horizons 3/12/2026 9:18:15 AM \| Browse: 10 \| Download: 54
6	Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes 3/6/2026 8:56:27 AM \| Browse: 35 \| Download: 148
7	Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation 2/27/2026 8:35:11 AM \| Browse: 17 \| Download: 89
8	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 47 \| Download: 218
9	Liver clock: Malalignment and entrainment therapeutics 2/11/2026 3:41:43 AM \| Browse: 33 \| Download: 84
10	Fatty pancreas: Current insights and future perspectives 2/10/2026 10:35:39 AM \| Browse: 33 \| Download: 88
11	Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies 2/6/2026 8:43:37 AM \| Browse: 61 \| Download: 126
12	High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health 2/2/2026 7:26:02 AM \| Browse: 38 \| Download: 134
13	Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:32 AM \| Browse: 43 \| Download: 170
14	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 37 \| Download: 140
15	Impact of multidisciplinary steatotic liver disease management on bariatric surgery referral and clinical outcomes: A retrospective cohort study 1/27/2026 10:12:31 AM \| Browse: 35 \| Download: 118
16	Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction 1/27/2026 10:12:31 AM \| Browse: 40 \| Download: 124
17	Metabolic-dysfunction associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review 1/15/2026 8:12:50 AM \| Browse: 36 \| Download: 85
18	Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches 1/12/2026 9:50:50 AM \| Browse: 31 \| Download: 78
19	Serum uric acid-to-high-density lipoprotein cholesterol ratio and cardiovascular risk in Asian patients with metabolic dysfunction-associated steatotic liver disease 12/27/2025 2:50:52 AM \| Browse: 51 \| Download: 195
20	Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption? 12/26/2025 10:27:35 AM \| Browse: 61 \| Download: 182
21	Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients 12/26/2025 10:27:34 AM \| Browse: 70 \| Download: 302
22	Integrated serum metabolomics reveal molecular mechanism of Xietu Hemu prescription on metabolic dysfunction-associated steatotic liver disease-related obesity 12/26/2025 10:27:31 AM \| Browse: 62 \| Download: 247
23	Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health 12/26/2025 10:27:30 AM \| Browse: 75 \| Download: 235
24	Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease 12/22/2025 7:43:01 AM \| Browse: 57 \| Download: 179
25	Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease 12/19/2025 10:39:41 AM \| Browse: 67 \| Download: 274
26	Artificial intelligence applications for managing metabolic dysfunction-associated steatotic liver disease: Current status and future prospects 12/19/2025 10:39:40 AM \| Browse: 58 \| Download: 233
27	Role of sodium-glucose co-transporter 2 inhibitors in liver diseases 12/19/2025 8:32:37 AM \| Browse: 57 \| Download: 198
28	Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients 12/15/2025 9:46:09 AM \| Browse: 40 \| Download: 167
29	Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis 12/10/2025 7:48:07 AM \| Browse: 101 \| Download: 274
30	Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends 12/5/2025 11:28:02 AM \| Browse: 78 \| Download: 190
31	Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges 12/3/2025 9:10:07 AM \| Browse: 108 \| Download: 252
32	Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes 11/27/2025 7:54:00 AM \| Browse: 71 \| Download: 212
33	Impact of alcohol-associated and metabolic dysfunction-associated steatotic liver diseases upon hepatic disorder and carcinogenesis in the current era 11/27/2025 7:53:59 AM \| Browse: 66 \| Download: 204
34	Genetic predeterminants and recent advancements in steatotic liver disease: A roadmap toward precision hepatology 11/27/2025 7:53:58 AM \| Browse: 57 \| Download: 202
35	Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis 11/27/2025 7:53:58 AM \| Browse: 65 \| Download: 265
36	Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Machine learning for non-invasive diagnosis and risk stratification 11/27/2025 7:53:57 AM \| Browse: 47 \| Download: 153
37	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 51 \| Download: 174
38	Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action 11/27/2025 7:53:52 AM \| Browse: 51 \| Download: 182
39	Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease 11/26/2025 3:57:03 AM \| Browse: 65 \| Download: 244
40	Clinical significance and pathogenic mechanisms of fatigue in metabolic dysfunction-associated steatotic liver disease 10/27/2025 10:57:53 AM \| Browse: 168 \| Download: 291
41	Hepatocyte nuclear factors dynamically regulate triglyceride metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease: Mechanisms and implications 10/27/2025 10:57:50 AM \| Browse: 183 \| Download: 205
42	Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice 10/27/2025 10:57:49 AM \| Browse: 143 \| Download: 300
43	Helicobacter pylori infection as a risk factor in the development of Metabolic dysfunction-associated steatotic liver disease 10/27/2025 10:57:49 AM \| Browse: 159 \| Download: 235
44	Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease 10/27/2025 8:08:13 AM \| Browse: 165 \| Download: 367
45	Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus 10/15/2025 9:03:22 AM \| Browse: 83 \| Download: 481
46	Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases 9/25/2025 11:24:06 AM \| Browse: 94 \| Download: 120
47	From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease 9/25/2025 11:24:04 AM \| Browse: 139 \| Download: 218
48	Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation 9/25/2025 11:24:01 AM \| Browse: 129 \| Download: 260
49	Silymarin-alpha lipoic acid and metabolic dysfunction-associated steatotic liver disease: Insights and methodological considerations 9/25/2025 11:24:00 AM \| Browse: 100 \| Download: 203
50	Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool 9/25/2025 3:33:09 AM \| Browse: 116 \| Download: 152